Healio
SearchLoading
Healio
SearchLoading
More about

Disitamab Vedotin

News
September 07, 2023
2 min watch
Save

VIDEO: 'Exciting' areas of research in metastatic breast cancer

Healio spoke with Sara M. Tolaney, MD, MPH, about the latest research in metastatic breast cancer.

News
September 28, 2020
1 min read
Save

FDA grants breakthrough therapy designation to RC48 for urothelial cancer

The FDA granted breakthrough therapy designation to disitamab vedotin for treatment of certain patients with urothelial cancer, according to the agent’s manufacturer.